GGrantIndex
Sort

64,565 grants matching drug discovery

Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology

$707,331
Laura M Bohn · Scripps Florida · R01 · FY2014 · DA

Regulation of the biosynthesis of a novel class of anti-diabetic lipids

$707,327
Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK

Regulation of the biosynthesis of a novel class of anti-diabetic lipids

$707,327
Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK

Discovery of mGlu receptor PAMs for treatment of schizophrenia

$707,149
P Jeffrey Conn · Vanderbilt University · R01 · FY2022 · MH

Developing Novel Arginine Biased Arrays for Epigenetic Research

$707,105
Zu-Wen Sun · Epicypher, Inc. · R44 · FY2018 · GM

Network Resource

$707,061
Sook Wah Yee · University Of California, San Francisco · U19 · FY2011 · GM

Clinical translation of a NexGen platform for quantifying protein networks in human biospecimens

$707,046
Amanda G Paulovich · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA

Analysis of protein interactions in neurodegenerative disease

$706,934
John Robert Yates · Scripps Research Institute, The · R01 · FY2024 · AG

Analysis of protein interactions in neurodegenerative disease

$706,934
John Robert Yates · Scripps Research Institute, The · R01 · FY2023 · AG

Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines

$706,916
George M Shaw · University Of Pennsylvania · R01 · FY2019 · AI

Expanding Genetic Understanding of Depression, Anxiety, and their Treatments

$706,877
Joel Gelernter · Yale University · R01 · FY2024 · MH

Leadership Planning and Evaluation

$706,824
Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2025 · CA

AI-Powered Quantitative Systems Pharmacology for AD Drug Repurposing

$706,510
Lei Xie · Hunter College · R01 · FY2025 · AG

Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenation

$706,471
Emilia Entcheva · George Washington University · R01 · FY2020 · HL

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

$706,465
Kim L Brouwer · Univ Of North Carolina Chapel Hill · T32 · FY2021 · GM

Lung cancer oncogenotype-selective drug target discovery

$706,409
Michael G Roth · Ut Southwestern Medical Center · U01 · FY2015 · CA

Lung cancer oncogenotype-selective drug target discovery

$706,409
Michael G Roth · Ut Southwestern Medical Center · U01 · FY2016 · CA

Structural Basis of Protease-Activated Receptor Function

$706,394
Shaun R. Coughlin · University Of California, San Francisco · R01 · FY2017 · HL

IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL

$706,324
Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2024 · HL

Systems genetics of premorbid and cocaine use traits in a rat reduced complexity cross

$706,305
Kathleen M. Kantak · Boston University Medical Campus · U01 · FY2023 · DA

Multiplex cell-based platform for kinase drug discovery

$706,212
Peter Krutzik · Primity, Inc. · R44 · FY2014 · CA

Stroke Treatment by Chemically-induced Hypothermia

$706,207
Thomas A. Dix · Jt Pharmaceuticals, Inc. · R42 · FY2016 · NS

Northeast Node of the National Drug Abuse Clinical Trials Network

$706,190
Lisa A Marsch · Dartmouth College · UG1 · FY2019 · DA

Discovery of Novel Benzimidazole Resistance Mechanisms

$706,189
Erik Christian Andersen · Johns Hopkins University · R01 · FY2024 · AI

DCTD Preclinical In Vivo/In Vitro Assay Development

$706,171
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA